125 related articles for article (PubMed ID: 15315339)
1. Expression of CD80/CD86 and CTLA-4 mRNA in peripheral blood mononuclear cells of the patients with systemic lupus erythematosus.
Liu W; Li J
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):247-9. PubMed ID: 15315339
[TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus.
Hu S; Tao D; He P
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):245-6, 265. PubMed ID: 15315338
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
Liu MF; Li JS; Weng TH; Lei HY
Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
[TBL] [Abstract][Full Text] [Related]
4. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients.
Folzenlogen D; Hofer MF; Leung DY; Freed JH; Newell MK
Clin Immunol Immunopathol; 1997 Jun; 83(3):199-204. PubMed ID: 9175908
[TBL] [Abstract][Full Text] [Related]
6. Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
Liu MF; Liu HS; Wang CR; Lei HY
J Clin Immunol; 1998 Nov; 18(6):392-8. PubMed ID: 9857283
[TBL] [Abstract][Full Text] [Related]
7. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
8. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus.
Abe K; Takasaki Y; Ushiyama C; Asakawa J; Fukazawa T; Seki M; Hirashima M; Ogaki M; Hashimoto H
J Clin Immunol; 1999 Jan; 19(1):58-66. PubMed ID: 10080105
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of liver infiltrating CD86-positive mononuclear cells for diagnosis of autoimmune hepatitis.
Kurokohchi K; Masaki T; Himoto T; Deguchi A; Nakai S; Morishita A; Yoneyama H; Kimura Y; Watanabe S; Kuriyama S
World J Gastroenterol; 2006 Apr; 12(16):2523-9. PubMed ID: 16688797
[TBL] [Abstract][Full Text] [Related]
12. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
13. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis.
Summers KL; O'Donnell JL; Williams LA; Hart DN
Arthritis Rheum; 1996 Aug; 39(8):1287-91. PubMed ID: 8702435
[TBL] [Abstract][Full Text] [Related]
15. Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients.
Hirashima M; Fukazawa T; Abe K; Morita Y; Kusaoi M; Hashimoto H
Lupus; 2004; 13(1):24-31. PubMed ID: 14870914
[TBL] [Abstract][Full Text] [Related]
16. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
17. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A; Waters E; Rowshanravan B; Hinze C; Williams C; Janman D; Fox TA; Booth C; Pesenacker AM; Halliday N; Soskic B; Kaur S; Qureshi OS; Morris EC; Ikemizu S; Paluch C; Huo J; Davis SJ; Boucrot E; Walker LSK; Sansom DM
Nat Immunol; 2022 Sep; 23(9):1365-1378. PubMed ID: 35999394
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
Chattopadhyay G; Shevach EM
J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
[TBL] [Abstract][Full Text] [Related]
19. CD80 expression is induced on activated B cells following stimulation by CD86.
Sahoo NC; Rao KV; Natarajan K
Scand J Immunol; 2002 Jun; 55(6):577-84. PubMed ID: 12028560
[TBL] [Abstract][Full Text] [Related]
20. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
